Page 2 - கேட்லின் கருசோ கூர்மையான News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கேட்லின் கருசோ கூர்மையான. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கேட்லின் கருசோ கூர்மையான Today - Breaking & Trending Today

Clover Biopharmaceuticals Raises $230 Million in Oversubscribed Series C Financing

Clover Biopharmaceuticals Raises $230 Million in Oversubscribed Series C Financing
News provided by
Share this article
Share this article
Series C financing brings total capital raised in the last 12 months to over US$ 400 million (>RMB 2.5 billion)
The proceeds will support the continued development and expansion of Clover s pipeline of protein-based vaccines and biologic cancer therapies
CHENGDU, China, Feb. 22, 2021 /PRNewswire/ Clover Biopharmaceuticals, a global clinical-stage biotechnology company developing transformative biologics as vaccines and therapeutics for the world s most debilitating diseases, today announced the completion of an oversubscribed $230 million Series C financing. This financing round brings Clover s total capital raised in the last 12 months to over $400 million (over RMB 2.5 billion). The Series C round was co-led by GL Ventures and Temasek, with participation from Oceanpine Capital, OrbiMed and existing investor Delos Ca ....

Michael Yi , Temasek Charter , Katelyn Caruso Sharpe , Joshua Liang , Public Affairs , Lifesci Communications , European Union , Clover Biopharmaceuticals , Oceanpine Capital , Chief Executive Officer , Board Director , Hillhouse Capital , Qualified Person , Transforming Economies , Growing Middle Income Populations , Deepening Comparative Advantages , Biopharmaceuticals Contacts , மைக்கேல் இ , தேமாஸேக் சாசனம் , கேட்லின் கருசோ கூர்மையான , ஜோஷுவா லியாங் , பொது வாழ்க்கைத்தொழில்கள் , ஐரோப்பிய தொழிற்சங்கம் , க்ளோவர் உயிர் மருந்துகள் , தலைமை நிர்வாகி அதிகாரி , பலகை இயக்குனர் ,

Clover Biopharmaceuticals Raises $230 Million in Oversubscribed Series C Financing

Clover Biopharmaceuticals Raises $230 Million in Oversubscribed Series C Financing
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Michael Yi , Temasek Charter , Katelyn Caruso Sharpe , Joshua Liang , Public Affairs , Lifesci Communications , European Union , Chief Executive Officer , Board Director , Hillhouse Capital , Qualified Person , Transforming Economies , Growing Middle Income Populations , Deepening Comparative Advantages , Biopharmaceuticals Contacts , மைக்கேல் இ , தேமாஸேக் சாசனம் , கேட்லின் கருசோ கூர்மையான , ஜோஷுவா லியாங் , பொது வாழ்க்கைத்தொழில்கள் , ஐரோப்பிய தொழிற்சங்கம் , தலைமை நிர்வாகி அதிகாரி , பலகை இயக்குனர் , ஹில்ஹவுஸ் மூலதனம் , தகுதி நபர் , மாற்றும் பொருளாதாரங்கள் ,

Clover Biopharmaceuticals Raises $230 Million in Oversubscribed Series C Financing

Clover Biopharmaceuticals Raises $230 Million in Oversubscribed Series C Financing
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Michael Yi , Temasek Charter , Katelyn Caruso Sharpe , Joshua Liang , Public Affairs , Lifesci Communications , European Union , Clover Biopharmaceuticals , Oceanpine Capital , Chief Executive Officer , Board Director , Hillhouse Capital , Qualified Person , Transforming Economies , Growing Middle Income Populations , Deepening Comparative Advantages , Biopharmaceuticals Contacts , மைக்கேல் இ , தேமாஸேக் சாசனம் , கேட்லின் கருசோ கூர்மையான , ஜோஷுவா லியாங் , பொது வாழ்க்கைத்தொழில்கள் , ஐரோப்பிய தொழிற்சங்கம் , க்ளோவர் உயிர் மருந்துகள் , தலைமை நிர்வாகி அதிகாரி , பலகை இயக்குனர் ,

Clover and Dynavax Announce Planned Global Phase 2/3 Efficacy Trial of Adjuvanted COVID-19 Vaccine Candidate

/PRNewswire/ Clover Biopharmaceuticals (Clover), a global clinical-stage biotechnology company committed to developing transformative biologics as vaccines. ....

City Of , United Kingdom , Dynavax Cp , Derek Cole , Richard Hatchett , Ryan Spencer , Katelyn Caruso Sharpe , Nicole Arndt , Joshua Liang , London Stock Exchange , Drug Administration , Dynavax Technologies Corporation , Coalition For Epidemic Preparedness Innovations , Exchange Commission , Lifesci Communications , Public Affairs , European Union , Investor Relations Advisory Solutions , Epidemic Preparedness Innovations , Chief Executive Officer , Clover Biopharmaceuticals , Spencer Chief Executive Officer , Qualified Person , Middle East Respiratory Syndrome , Rift Valley Fever , Annual Report ,

Clover Biopharmaceuticals Announces Publication of Phase 1 Clinical Trial Data for its Adjuvanted COVID-19 Vaccine Candidates in The Lancet

Press release content from PR Newswire. The AP news staff was not involved in its creation.
Clover Biopharmaceuticals Announces Publication of Phase 1 Clinical Trial Data for its Adjuvanted COVID-19 Vaccine Candidates in The Lancet
February 1, 2021 GMT
Clover LOGO (PRNewsfoto/三叶草生物制药有限公司)
Adjuvanted S-Trimer COVID-19 vaccine candidates demonstrated favorable safety and tolerability profiles and strong neutralizing immune responses in a phase 1 trial
Clover plans to initiate a global phase 2/3 trial in the first half of 2021 with an interim analysis for vaccine efficacy potentially in the middle of 2021
CHENGDU, China, Feb. 1, 2021 /PRNewswire/ Clover Biopharmaceuticals (Clover), a global clinical-stage biotechnology company committed to developing transformative biologics as vaccines and therapeutics for the world’s most debilitating diseases, today announced that the data from its Phase 1 clinical trial evaluating the safety and i ....

City Of , United Kingdom , Katelyn Caruso Sharpe , Ralf Clemens , London Stock Exchange , Vaccine Program , Dynavax Technologies Corporation , Coalition For Epidemic Preparedness Innovations , Lifesci Communications , Public Affairs , European Union , Adjuvanteds Trimer , Scientific Advisory Board , Epidemic Preparedness Innovations , Qualified Person , Middle East Respiratory Syndrome , Rift Valley Fever , Biopharmaceuticals Contact , Public Health , Products And Services , Coronavirus Pandemic , Product Testing , Severe Acute Respiratory Syndrome , Pharmaceutical Manufacturing , Health Care Industry , Pr Newswire ,